VP of Antibody Discovery and Engineering @ ChangChun GeneScience Pharmaceutical Co. Ltd. (July 2023 - April 2025)
VP of Target Mining and Assessment @ (August 2022 - June 2023)
Sr Director @ (June 2020 - July 2022)
Sr Director of Antibody Engineering @ (October 2017 - May 2020)
Investigator II @ (April 2010 - October 2017)
Postdoctoral Fellow @ Brandeis University / Harvard University (September 2003 - April 2010)
Ming Lei Education
Michigan State University
Doctor of Philosophy (Ph.D.) (Molecular Biophysics)
1997-2003
Tsinghua University
Bachelor's degree (Physics)
1992-1997
Ming Lei Skills
Antibodies
Antibody Discovery
Antibody Engineering
Artificial Intelligence (AI)
Biochemistry
Bioinformatics
Biologics
Biologics projects
Biotechnology
Cell Biology
Cell Culture
Drug Discovery
Laboratory
Lifesciences
Machine Learning
Molecular Biology
NGS
Protein Chemistry
Protein Engineering
Protein Purification
Science
Statistics
Target review
Team Leadership
Engineering
Management
Customer Service
Strategy
Design
Microsoft Office
Software
Ming Lei Summary
Ming Lei, based in Acton, MA, US, is currently a CTO at SuZhou XiaoLu Biomedicines. Ming Lei brings experience from previous roles at ChangChun GeneScience Pharmaceutical Co. Ltd., VelaVigo, BeiGene and WuXi Biologics. Ming Lei holds a 1997 - 2003 Doctor of Philosophy (Ph.D.) in Molecular Biophysics @ Michigan State University. With a robust skill set that includes Antibodies, Antibody Discovery, Antibody Engineering, Artificial Intelligence (AI), Biochemistry and more. Ming Lei has 1 mobile phone numbers on RocketReach.
Looking for a different Ming Lei?
Find contact details for 700 million professionals.